Home/Filings/4/0001179110-19-012105
4//SEC Filing

MEHTA VIREN 4

Accession 0001179110-19-012105

CIK 0001130598other

Filed

Nov 26, 7:00 PM ET

Accepted

Nov 27, 8:33 AM ET

Size

8.8 KB

Accession

0001179110-19-012105

Insider Transaction Report

Form 4
Period: 2019-11-25
MEHTA VIREN
Director
Transactions
  • Purchase

    Common Stock

    2019-11-25$0.20/sh+250,000$50,000250,857 total
  • Purchase

    Warrant (right to purchase)

    2019-11-25+250,000250,000 total
    Exercise: $0.20From: 2019-11-25Exp: 2024-11-25Common Stock (250,000 underlying)
Holdings
  • Common Stock

    (indirect: By LLC)
    54
  • Common Stock

    (indirect: By Foundation)
    56
Footnotes (4)
  • [F1]The common stock and warrants were acquired in a public offering, by Onconova Therapeutics, Inc, of units which included one share of common stock and one warrant. The public offering price for each unit was $0.20.
  • [F2]Includes 190 shares held jointly with Dr. Mehta's spouse.
  • [F3]Dr. Mehta, as managing member, has voting and dispositive power with regard to the shares held by Mehta Partners, LLC.
  • [F4]Dr. Mehta, as trustee, has voting and dispositive power with regard to the shares held by Viram Foundation.

Issuer

Onconova Therapeutics, Inc.

CIK 0001130598

Entity typeother

Related Parties

1
  • filerCIK 0001238969

Filing Metadata

Form type
4
Filed
Nov 26, 7:00 PM ET
Accepted
Nov 27, 8:33 AM ET
Size
8.8 KB